Mucous membrane pemphigoid: are laminin 5 antibodies a risk factor for laryngeal involvement?
AR Shipman,
Corresponding Author
AR Shipman
Department of Dermatology, Stoke Mandeville Hospital, Aylesbury, UK,
*Correspondence: AR Shipman. E-mail:
[email protected]Search for more papers by this author I Ali,
I Ali
Department of Dermatology, Churchill Hospital, Headington, Oxford, UK
Search for more papers by this author DF Murrell,
DF Murrell
Department of Dermatology, St. George Hospital, University of NSW, Sydney, NSW, Australia,
Search for more papers by this author F Wojnarowska,
F Wojnarowska
Department of Dermatology, Churchill Hospital, Headington, Oxford, UK
Search for more papers by this author
AR Shipman,
Corresponding Author
AR Shipman
Department of Dermatology, Stoke Mandeville Hospital, Aylesbury, UK,
*Correspondence: AR Shipman. E-mail:
[email protected]Search for more papers by this author I Ali,
I Ali
Department of Dermatology, Churchill Hospital, Headington, Oxford, UK
Search for more papers by this author DF Murrell,
DF Murrell
Department of Dermatology, St. George Hospital, University of NSW, Sydney, NSW, Australia,
Search for more papers by this author F Wojnarowska,
F Wojnarowska
Department of Dermatology, Churchill Hospital, Headington, Oxford, UK
Search for more papers by this author
First published: 20 January 2009
No abstract is available for this article.
References
- 1
Whiteside OJ,
Martinez Devesa P,
Ali I,
Capper JW.
Mucous membrane pemphigoid: nasal and laryngeal manifestations.
J Laryngol Otol
2003; 117: 885–888.
- 2
Allen J,
Phan TT,
Hughes MA,
Cherry GW,
Wojnarowska F.
The cellular origins of the linear IgA disease target antigens. an indirect immunofluorescence study using cultured human keratinocytes and fibroblasts.
Br J Derm
2003; 148: 945–953.
- 3
Bernard P,
Vaillant L,
Labeille B
et al
. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group [see comments].
Arch Dermatol
1995; 131: 48–52.
- 4
Chan LS,
Ahmed AR,
Anhalt GJ
et al
. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.
Arch Dermatol
2002; 138: 370–379.
- 5
Leverkus M,
Schmidt E,
Lazarova Z,
Brocker EB,
Yancey KB,
Zillikens D.
Antiepiligrin cicatricial pemphigoid.
Arch Dermatol
1999; 135:
1091–1098.
- 6
Lazarova Z,
Yee C,
Lazar J,
Yancey KB.
IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit.
Clin Immunol
2001; 101: 100–105.
- 7
Hamill KJ,
McLean WH.
The alpha-3 polypeptide chain of laminin 5: insight into wound healing responses from the study of genodermatoses.
Clin Exp Dermatol
2005; 30: 98–404.
- 8
McLean WH,
Irvine AD,
Hamill KJ
et al
. An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onychol-cutaneous syndrome.
Hum Mol Genet
2003; 12: 2395–2409.
- 9
Philips PS,
Amonoo-Kuofi K,
Hore ID,
Atherton DJ,
Albert DM.
Successful treatment of laryngeal stenosis in laryngo-onycho-cutaneous syndrome with topical mitomycin C.
Pediatr Dermatol
2006; 23: 75–77.
